GGrantIndex
← Leaderboards

Kaustubh Kale

Aventusoft, Llc

$12,111,822
Attributed
$12,111,822
Total exposure
9
Grants
9
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $3.4M · FY201425
$5M$3.8M$2.5M$1.3M$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$12,111,822 · 9

By mechanism

R44$10,348,817 · 4
R43$913,150 · 3
SB1$500,000 · 1
R41$349,855 · 1

Top collaborators

No co-investigators on record.

Others in their field

Top investigators on “Technology

Research focus

TechnologyDevicesMeasurementSmall Business Innovation Research GrantMonitorClinical PracticeInsightEvidence BaseInstitutional Review BoardsFloridaEchocardiographyBlood PressurePerformancePreventionCostHeart FailureMedicalDiagnosisAlgorithmsEarly DiagnosisCollaborationsCardiacPublic HealthLeft

Grant awards (22)

A mobile health framework for left ventricular end diastolic pressure diagnostics and monitoring.$860,397
R44 · FY2025 · HL · contact PI
Commercialization Readiness Pilot Program support for: HATS-OFF$500,000
SB1 · FY2025 · HL · contact PI
An Innovative AI-Powered Wearable Physiological Sensor System for Real-Time Pain Monitoring and Management (PainVitals)$349,855
R41 · FY2025 · GM · contact PI
A mobile health framework for left ventricular end diastolic pressure diagnostics and monitoring.$864,759
R44 · FY2024 · HL · contact PI
A mobile health framework for left ventricular end diastolic pressure diagnostics and monitoring.$399,999
R44 · FY2023 · HL · contact PI
Administrative Supplement to Promote Diversity in Research and Development Small Businesses-SBIR (EF)$74,836
R44 · FY2023 · HL · contact PI
A novel non-invasive device for screening and optimized management to improve heart failure outcomes in patients with diabetes mellitus$1,500,000
R44 · FY2022 · HL · contact PI
Non-invasive cloud connected device for hemodynamic-guided therapy toimprove outcomes for heart failure patients$1,500,000
R44 · FY2021 · HL · contact PI
A novel non-invasive device for screening and optimized management to improve heart failure outcomes in patients with diabetes mellitus$1,500,000
R44 · FY2021 · HL · contact PI
Innovative, non-invasive, battery-less, disposable cardiac biosensor for hemodynamic monitoring$225,000
R43 · FY2021 · EB · contact PI
Administrative Supplement to Promote Diversity in Research and Development Small Businesses-SBIR (Rodrigo Jordao)$134,079
R44 · FY2021 · HL · contact PI
Non-invasive cloud connected device for hemodynamic-guided therapy toimprove outcomes for heart failure patients$1,500,000
R44 · FY2020 · HL · contact PI
A novel non-invasive device for screening and optimized management to improve heart failure outcomes in patients with diabetes mellitus$400,000
R44 · FY2020 · HL · contact PI
Screening Under REgular assessment with hemoTAG (SURE TAG)$189,746
R44 · FY2020 · HL · contact PI
A mobile framework to measure ejection fraction by automated non-invasive analysis of cardiac signals$400,000
R44 · FY2019 · MD · contact PI
Non-invasive cloud connected device for hemodynamic-guided therapy toimprove outcomes for heart failure patients$225,001
R44 · FY2019 · HL · contact PI
A mobile framework to measure ejection fraction by automated non-invasive analysis of cardiac signals$400,000
R44 · FY2018 · MD · contact PI
A mobile framework to measure ejection fraction by automated non-invasive analysis of cardiac signals$400,000
R44 · FY2017 · MD · contact PI
Innovation for the earlydetection, diagnosis, and quantification of diabetic cardiomyopathy.$225,000
R43 · FY2017 · DK · contact PI
A mobile framework to measure ejection fraction by automated non-invasive analysi$200,000
R43 · FY2015 · MD · contact PI
A mobile framework to measure ejection fraction by automated non-invasive analysi$63,150
R43 · FY2015 · MD · contact PI
A mobile framework to measure ejection fraction by automated non-invasive analysi$200,000
R43 · FY2014 · MD · contact PI